Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer
Public ClinicalTrials.gov record NCT00744497. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Double-Blind Phase 3 Trial Comparing Docetaxel Combined With Dasatinib to Docetaxel Combined With Placebo in Castration-Resistant Prostate Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether survival can be prolonged in patients with castration-resistant prostate cancer who receive dasatinib with docetaxel and prednisone.
Study identification
- NCT ID
- NCT00744497
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,930 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2008 (Type not available)
- Primary completion
- Aug 2012 (Actual)
- Completion
- Jul 2015 (Actual)
- Last update posted
- Oct 17, 2016
2008 – 2015
United States locations
- U.S. sites
- 43
- U.S. states
- 23
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University Of South Alabama / Mitchell Cancer Institute | Mobile | Alabama | 36604 | — |
| Southern Cancer Center | Mobile | Alabama | 36608 | — |
| Alaska Clinical Research Center, Llc | Anchorage | Alaska | 99508 | — |
| Highlands Oncology Group | Fayetteville | Arkansas | 72703 | — |
| Compassionate Cancer Care Medical Group, Inc. | Corona | California | 92879 | — |
| Desert Hematology Oncology Medical Group | Rancho Mirage | California | 92270 | — |
| Compassionate Cancer Care Medical Group Inc | Riverside | California | 92501 | — |
| Sharp Clinical Oncology Research | San Diego | California | 92123 | — |
| Va San Diego Healthcare System | San Diego | California | 92161 | — |
| Edward Alexson, Md, Inc. | Santa Ana | California | 92705 | — |
| Connecticut Oncology Group | Middletown | Connecticut | 06457 | — |
| Va Connecticut Healthcare System | West Haven | Connecticut | 06516 | — |
| Gwinnett Hospital System Inc. | Lawrenceville | Georgia | 30046 | — |
| University Of Chicago | Chicago | Illinois | 60637 | — |
| Midwestern Regional Medical Center | Zion | Illinois | 60099 | — |
| Fort Wayne Medical Oncology And Hematology Inc | Fort Wayne | Indiana | 46845 | — |
| Cancer Center Of Kansas | Wichita | Kansas | 67214 | — |
| Maine Center For Cancer Medicine | Scarborough | Maine | 04074 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Jackson Oncology Associates, Pllc | Jackson | Mississippi | 39202 | — |
| North Mississippi Hematology And Oncology Associates, Ltd | Tupelo | Mississippi | 38801 | — |
| New York Oncology Hematology, Pc | Albany | New York | 12206 | — |
| New York Oncology Hematology, Pc | Albany | New York | 12208 | — |
| Samuel S. Stratton Vamc | Albany | New York | 12208 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Piedmont Hematology Oncology Associates, Pllc | Winston-Salem | North Carolina | 27103 | — |
| Summa Health System | Akron | Ohio | 44304 | — |
| Mid Ohio Oncology/Hematology, Inc,Dba | Columbus | Ohio | 43219 | — |
| Providence Portland Med Ctr | Portland | Oregon | 97213 | — |
| Regional Hemetology Oncology, Pc | Langhorne | Pennsylvania | 19047 | — |
| Upmc Cancer Pavilion | Pittsburgh | Pennsylvania | 15232 | — |
| Va Pittsburgh Healthcare System | Pittsburgh | Pennsylvania | 15240 | — |
| Associates In Hematology & Oncology, P.C. | Upland | Pennsylvania | 19013 | — |
| The Miriam Hospital | Providence | Rhode Island | 02906 | — |
| Cancer Centers Of The Carolinas | Greenville | South Carolina | 29615 | — |
| Boston Baskin Cancer Foundation | Memphis | Tennessee | 38120 | — |
| Cancer Specialists Of South Texas, Pa | Corpus Christi | Texas | 78412 | — |
| The University Of Texas Md Anderson Cancer Center | Houston | Texas | 77030 | — |
| Providence Regional Cancer System | Lacey | Washington | 98503 | — |
| University Of Washington | Seattle | Washington | 98109 | — |
| Dean Hematology And Oncology Clinic | Madison | Wisconsin | 53717 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 143 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00744497, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 17, 2016 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00744497 live on ClinicalTrials.gov.